Sally Del Principe
Corporate Officer/Principal at Lupton del Principe Associates Ltd.
Sally Del Principe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Lupton del Principe Associates Ltd. | Corporate Officer/Principal | 2010-04-08 | - |
Career history of Sally Del Principe
Former positions of Sally Del Principe
| Companies | Position | Start | End |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Director of Finance/CFO | 2010-04-08 | 2010-10-27 |
Statistics
International
| United States | 2 |
| United Kingdom | 2 |
Operational
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
| Lupton del Principe Associates Ltd. |
- Stock Market
- Insiders
- Sally Del Principe
- Experience
